| dc.contributor.author | Loach, Richard Peter | |
| dc.contributor.author | Movassaghi, Mohammad | |
| dc.contributor.author | Fenton, Owen Shea | |
| dc.date.accessioned | 2017-03-10T19:53:53Z | |
| dc.date.available | 2017-03-10T19:53:53Z | |
| dc.date.issued | 2016-01 | |
| dc.date.submitted | 2015-11 | |
| dc.identifier.issn | 0002-7863 | |
| dc.identifier.issn | 1520-5126 | |
| dc.identifier.uri | http://hdl.handle.net/1721.1/107391 | |
| dc.description.abstract | The concise, enantioselective total syntheses of (+)-asperazine (1), (+)-iso-pestalazine A (2), and (+)-pestalazine A (3) have been achieved by the development of a late-stage C3–C8′ Friedel–Crafts union of polycyclic diketopiperazines. Our modular strategy enables the union of complex polycyclic diketopiperazines in virtually their final forms, thus providing rapid and highly convergent assembly at the challenging quaternary stereocenter of these dimeric alkaloids. The significance of this carbon–carbon bond formation can be gauged by the manifold constraints that were efficiently overcome, namely the substantial steric crowding at both reactive sites, the nucleophilic addition of C8′ over N1′ to the C3 carbocation, and the multitude of reactivity posed by the use of complex diketopiperazine fragments in the coupling event. The success of the indoline π-nucleophile that evolved through our studies is notable given the paucity of competing reaction pathways observed in the presence of the highly reactive C3 carbocation generated. This first total synthesis of (+)-pestalazine A also allowed us to revise the molecular structure for this natural alkaloid. | en_US |
| dc.description.sponsorship | National Institute of General Medical Sciences (U.S.) (Grant GM089732) | en_US |
| dc.description.sponsorship | Amgen Inc. | en_US |
| dc.description.sponsorship | Fonds de Recherche du Québec | en_US |
| dc.language.iso | en_US | |
| dc.publisher | American Chemical Society | en_US |
| dc.relation.isversionof | http://dx.doi.org/10.1021/jacs.5b12392 | en_US |
| dc.rights | Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use. | en_US |
| dc.source | PMC | en_US |
| dc.title | Concise Total Synthesis of (+)-Asperazine, (+)-Pestalazine A, and (+)-iso-Pestalazine A. Structure Revision of (+)-Pestalazine A | en_US |
| dc.type | Article | en_US |
| dc.identifier.citation | Loach, Richard P., Owen S. Fenton, and Mohammad Movassaghi. “Concise Total Synthesis of (+)-Asperazine, (+)-Pestalazine A, and (+)- Iso -Pestalazine A. Structure Revision of (+)-Pestalazine A.” Journal of the American Chemical Society 138.3 (2016): 1057–1064. | en_US |
| dc.contributor.department | Massachusetts Institute of Technology. Department of Chemistry | en_US |
| dc.contributor.department | Koch Institute for Integrative Cancer Research at MIT | en_US |
| dc.contributor.mitauthor | Loach, Richard Peter | |
| dc.contributor.mitauthor | Fenton, Owen S. | |
| dc.contributor.mitauthor | Movassaghi, Mohammad | |
| dc.relation.journal | Journal of the American Chemical Society | en_US |
| dc.eprint.version | Author's final manuscript | en_US |
| dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
| eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
| dspace.orderedauthors | Loach, Richard P.; Fenton, Owen S.; Movassaghi, Mohammad | en_US |
| dspace.embargo.terms | N | en_US |
| dc.identifier.orcid | https://orcid.org/0000-0002-4426-7474 | |
| dc.identifier.orcid | https://orcid.org/0000-0002-5585-9280 | |
| dc.identifier.orcid | https://orcid.org/0000-0003-3080-1063 | |
| mit.license | PUBLISHER_POLICY | en_US |
| mit.metadata.status | Complete | |